{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:40:40Z","timestamp":1793691640432,"version":"4.5.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003009","name":"Egyptian Science and Technology Development Fund","doi-asserted-by":"crossref","award":["457"],"award-info":[{"award-number":["457"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12985-016-0572-9","type":"journal-article","created":{"date-parts":[[2016,6,29]],"date-time":"2016-06-29T21:00:48Z","timestamp":1467234048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Characterization of differential antibody production against hepatitis C virus in different HCV infection status"],"prefix":"10.1186","volume":"13","author":[{"given":"Mona","family":"Rafik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salwa","family":"Bakr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-9853","authenticated-orcid":false,"given":"Dina","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid Abd","family":"ElHady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Samir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"572_CR1","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1073\/pnas.1008877107","volume":"107","author":"F Miller","year":"2010","unstructured":"Miller F, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci. 2010;107:14757\u201362.","journal-title":"Proc Natl Acad Sci"},{"key":"572_CR2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107\u201315.","journal-title":"Clin Microbiol Infect"},{"key":"572_CR3","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1093\/emboj\/20.14.3840","volume":"20","author":"Z Xu","year":"2001","unstructured":"Xu Z, Choi J, Yen TS, Lu W, Strohecker A, Govindarajan S, Chien D, Selby M, Ou J. Synthesis of a novel hepatitis C virus protein by ribosomal frame shift. EMBO J. 2001;20:3840\u201348.","journal-title":"EMBO J"},{"key":"572_CR4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","volume":"5","author":"D Moradpour","year":"2007","unstructured":"Moradpour D, Penin F, Rice C. Replication of hepatitis C virus. Nat Rev Microbiol. 2007;5:453\u201363.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"572_CR5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jviromet.2010.10.020","volume":"171","author":"J Gutierrez","year":"2011","unstructured":"Gutierrez J, Klepper A, Garber J, Walewski J, Bateman K, Khaitova V, Syder A, Tscherne D, Gauthier A, Jefferson D, Rice C, Schiano T, Branch AD. Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods. 2011;171(1):169\u201375.","journal-title":"J Virol Methods"},{"key":"572_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1743-422X-6-84","volume":"6","author":"M Sillanp\u00e4\u00e4","year":"2009","unstructured":"Sillanp\u00e4\u00e4 M, Mel\u00e9n K, Porkka P, Fagerlund R, Nevalainen K, Lappalainen M, Julkunen I. Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection. Virol J. 2009;6:84.","journal-title":"Virol J"},{"key":"572_CR7","first-page":"15","volume":"5","author":"V Barban","year":"2000","unstructured":"Barban V, Fraysse-Corgier S, Paranhos-Baccala G, Petit M, Manin C, Berard Y, Prince A, Mandrand B, Meulien P. Identification of a human epitope in hepatitis C virus (HCV) core protein using a molecularly cloned antibody repertoire from a non-symptomatic, anti-HCV-positive patient. J Genral Virology. 2000;5:15\u201327.","journal-title":"J Genral Virology"},{"key":"572_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0140-6736(91)90942-I","volume":"337","author":"CL Poel Van der","year":"1991","unstructured":"Van der Poel CL, Cuypers HTM, Reesink HW. Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay. Lancet. 1991;337:317\u201319.","journal-title":"Lancet"},{"issue":"1","key":"572_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1590\/0037-8682-0222-2013","volume":"47","author":"F Pereira","year":"2014","unstructured":"Pereira F, Sant'ana Zarife M, Gomes Reis EA, Reis MG. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors. Rev Soc Bras Med Trop. 2014;47(1):12\u20137.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"7","key":"572_CR10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1373\/clinchem.2010.158691","volume":"57","author":"K Lai","year":"2011","unstructured":"Lai K, Jin M, Yuan S, Larson MF, Dominitz JA, Bankson DD. Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay. Clin Chem. 2011;57(7):1050\u20136.","journal-title":"Clin Chem"},{"key":"572_CR11","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/j.1537-2995.2008.01886.x","volume":"48","author":"A Contreraset","year":"2008","unstructured":"Contreraset A, Tornero-Romo C, Toribio J, Celis A, Orozco- Hernandez A, Rivera P. Very low hepatitis C antibody levels predict false-positive results and avoid supplemental testing. Transfusion. 2008;48:2540\u201348.","journal-title":"Transfusion"},{"issue":"Suppl 1","key":"572_CR12","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/cid\/cis368","volume":"55","author":"S Kamili","year":"2012","unstructured":"Kamili S, Drobeniuc J, Araujo A, Hayden T. Laboratory diagnostics for hepatitis C virus infection. Clin Infect Dis. 2012;55 Suppl 1:S43\u201348.","journal-title":"Clin Infect Dis"},{"key":"572_CR13","first-page":"456","volume-title":"Molecular diagnostics for clinical laboratorian","author":"D Dufour","year":"2005","unstructured":"Dufour D. Hepatitis C. In: Coleman W, Tsongalis G, Lawrence M, editors. Molecular diagnostics for clinical laboratorian. New Jersy: Humana Press; 2005. p. 456."},{"issue":"No. RR-3","key":"572_CR14","first-page":"1","volume":"52","author":"CDC","year":"2003","unstructured":"CDC. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR. 2003;52(No. RR-3):1\u201313.","journal-title":"MMWR"},{"issue":"18","key":"572_CR15","first-page":"362","volume":"62","author":"Centers for Disease Control and Prevention (CDC)","year":"2013","unstructured":"Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep. 2013;62(18):362\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"572_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13102818.2007.10817420","volume":"21","author":"D Stankovi\u0107-Djordjevi\u0107","year":"2007","unstructured":"Stankovi\u0107-Djordjevi\u0107 D, Tasi\u0107 G, Dini\u0107 M, Miladinovi\u0107-Tasi\u0107 N, Stojanovi\u0107 P, Bogdanovi\u0107 M. Hepatities C virus (HCV) viremia in patients with indeterminate second-generation HCV recombinant immunoblot assay. Biotechnol Biotechnol Equipment. 2007;21(1):83\u20135.","journal-title":"Biotechnol Biotechnol Equipment"},{"key":"572_CR17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1537-2995.2009.02103.x","volume":"49","author":"M Bes","year":"2009","unstructured":"Bes M, Esteban J, Casamitjana N, Piron M, Quer J, Cubero M. Hepatitis C virus (HCV)-specific T-cell responses among recombinant immunoblot assay-3-indeterminate blood donors: a confirmatory evidence of HCV exposure. Transfusion. 2009;49:1296\u2013305.","journal-title":"Transfusion"},{"key":"572_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2893.2005.00673.x","volume":"13","author":"M Rios","year":"2006","unstructured":"Rios M, Diago M, Rivera P, Tuset C, Cors R, Garcia V. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus. J Viral Hepatitis. 2006;13:177\u201381.","journal-title":"J Viral Hepatitis"},{"issue":"9","key":"572_CR19","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1111\/j.1537-2995.2011.03524.x","volume":"52","author":"A Makuria","year":"2012","unstructured":"Makuria A, Raghuraman S, Burbelo P, Cantilena C, Allison R, Gibble J, Rehermann B, Alter H. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling. Transfusion. 2012;52(9):1940\u201348.","journal-title":"Transfusion"},{"key":"572_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/jhep.2001.21905","volume":"33","author":"L Seeff","year":"2001","unstructured":"Seeff L, Hollinger Fand Alter H. Long-term mortality and morbidity of transfusion-associated non- A, non-B and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology. 2001;33:455\u201363.","journal-title":"Hepatology"},{"key":"572_CR21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jmv.21082","volume":"80","author":"A Muerhoff","year":"2008","unstructured":"Muerhoff A, Gutierrez R, Kyrk C, Leary T, Schlauder G, Dawson G, Desai SM. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies. J Med Virol. 2008;80:411\u201318.","journal-title":"J Med Virol"},{"issue":"4","key":"572_CR22","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/hep.510290442","volume":"29","author":"M Beld","year":"1999","unstructured":"Beld M, Penning M, Van Putten M, Lukashov V, Van Den Hoek A, Mcmorrow M, Goudsmit J. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: Impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology. 1999;29(4):1288\u201398.","journal-title":"Hepatology"},{"key":"572_CR23","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1172\/JCI10323","volume":"106","author":"D Kittlesen","year":"2000","unstructured":"Kittlesen D, Chianese-Bullock K, Yao Z, Braciale T, Hahn Y. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest. 2000;106:1239\u201349.","journal-title":"J Clin Invest"},{"key":"572_CR24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jhep.2008.12.026","volume":"50","author":"N Dionisio","year":"2009","unstructured":"Dionisio N, Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, Benedicto I, Rosado J, Salido G,Gonzalez-Gallego J. Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J Hepatol. 2009;50:872\u201382.","journal-title":"J Hepatol"},{"issue":"1","key":"572_CR25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0016-5085(99)70237-4","volume":"116","author":"M Chen","year":"1999","unstructured":"Chen M, Sallberg M, Sonnerborg A, Weiland O, Mattsson L, Jin L, Birkett A, Peterson D, Milich DR. Limited humoral immunity in hepatitis C virus infection. Gastroenterology. 1999;116(1):135\u201343.","journal-title":"Gastroenterology"},{"key":"572_CR26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/hep.510230501","volume":"23","author":"N Yuki","year":"1996","unstructured":"Yuki N, Hayashi N, Kasahara A. Quantitative analysis of antibody to hepatitis Cvirus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection. Hepatology. 1996;23:947\u201352.","journal-title":"Hepatology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-016-0572-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T13:29:56Z","timestamp":1498310996000},"score":1,"resource":{"primary":{"URL":"http:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-016-0572-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1186\/s12985-016-0572-9","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]},"article-number":"116"}}